Skip to main content
Moderate-to-severe atopic dermatitis: Astegolimab fails to reduce disease severity in phase 2 trial
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Moderate-to-severe atopic dermatitis: Astegolimab fails to reduce disease severity in phase 2 trial
User login
Username
Password
Reset your password
Concept
Lead
score
Dermatitis
1
1
Atopic Dermatitis
0
1
Biologic Therapy
0
0.85
Clinical Research
0
0.18
Eczema
0
0.18
Severity Index
0
0.18
Specialty
Lead
score
Dermatology
1
1
Allergy & Clinical Immunology
0
1
Family Medicine/Primary Care
0
1
Edit Tags